Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Phillip Shepherd, Karen L. Sheath, Sandar Tin Tin, Prashannata Khwaounjoo, Phyu S. Aye, Angie Li, George R. Laking, Nicola J. Kingston, Christopher A. Lewis, J. Mark Elwood, Donald R. Love, Mark J. McKeage
Published Sep 16, 2017 · Vol. 8, No. 60 · pp. 101437-101451
Sarah M. Schwarzenböck, Jan Stenzel, Thomas Otto, Heike V. Helldorff, Carina Bergner, Jens Kurth, Stefan Polei, Tobias Lindner, Romina Rauer, Alexander Hohn, Oliver W. Hakenberg, Hans J. Wester, Brigitte Vollmar, Bernd J. Krause
Published Sep 16, 2017 · Vol. 8, No. 56 · pp. 95606-95619
Judit Fazekas-Singer, Neydher Berroterán-Infante, Christina Rami-Mark, Monika Dumanic, Miroslawa Matz, Michael Willmann, Fritz Andreae, Josef Singer, Wolfgang Wadsak, Markus Mitterhauser, Erika Jensen-Jarolim
Published Sep 15, 2017 · Vol. 8, No. 47 · pp. 83128-83141